Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot study.
General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation.
Other noninfectious inflammatory disorders.
Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practices.
The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran.
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.
Patient wins right to care at home.
Using EP50 to forecast treatment adherence in individuals with multiple sclerosis.
CellCept (Product Insert)
Volumetric and Shape Analysis of the Thalamus and Striatum in Amnestic Mild Cognitive Impairment.
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.
Coexistence of rheumatoid arthritis, ankylosing spondylitis and dermatomyositis in a patient with diabetes mellitus and the associated linked HLA antigens.
Personalised medicine for multiple sclerosis care.
Time interval after ischaemic preconditioning affects neuroprotection and gliosis in the gerbil hippocampal CA1 region induced by transient cerebral ischaemia.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Evaluation of Patients with Refractory Chronic Inflammatory Demyelinating Polyneuropathy.
Corrigendum to "Expression of DNA methylation genes in secondary progressive multiple sclerosis" [J. Neuroimmunol. 290 (2016 Jan. 15) 66-9].
Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.
Genetic modifications associated with ketogenic diet treatment in the BTBR(T+Tf/J) mouse model of autism spectrum disorder.
Headache in stroke according to National Acute Stroke Israeli Survey.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Ingested (oral) rituximab inhibits EAE.
Comparison of Percutaneous Retrograsserian Balloon Compression and Gamma Knife Radiosurgery for the Treatment of Trigeminal Neuralgia in Multiple Sclerosis: A Clinical Research Study Article.
Lumican negatively controls the pathogenicity of murine encephalitic TH17 cells.
Anterior disco-osteo-arterial conflict as a cause of intersegmental arterial flow impairment and spinal cord ischemia.
Pages
« first
‹ previous
…
714
715
716
717
718
719
720
721
722
…
next ›
last »